Filing Flows › Pharma-Bio Serv (PBSV) › How it makes money
How Pharma-Bio Serv (PBSV) makes money
Pharma-Bio Serv (PBSV) made $2.3M of revenue in the third quarter fiscal 2026 (Q3 FY26), +19% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 FY26 | % of revenue |
|---|---|---|
| Revenue | $2.3M | 100.0% |
| Income tax | $3K | 0.1% |
| Operating cash flow | $61K | 2.6% |
| Free cash flow | $60K | 2.5% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 FY26 | $2.3M | +19% |
| Q2 FY26 | $2.7M | +12% |
| Q1 FY26 | $2.3M | -7% |
| Q4 FY25 | $2.1M | -8% |
| Q3 FY25 | $2.0M | -19% |
| Q2 FY25 | $2.4M | +2% |
| Q4 FY24 | $2.3M | -35% |
From Pharma-Bio Serv's 10-Q filed Sep 14, 2026 (on EDGAR).
Questions
How does Pharma-Bio Serv make money?
Pharma-Bio Serv (PBSV) made $2.3M of revenue in the third quarter fiscal 2026 (Q3 FY26), +19% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.